Neuropeptide Receptors in Intestinal Disease: Physiology and Therapeutic Potential

Author(s): Susanne A. Snoek, Keren S. Borensztajn, Rene M. van den Wijngaard, Wouter J. de Jonge

Journal Name: Current Pharmaceutical Design

Volume 16 , Issue 9 , 2010

Become EABM
Become Reviewer
Call for Editor


The autonomous nervous system of the gut is increasingly recognized as an important regulatory factor in intestinal permeability and immune cell activation. Neuropeptides released by neurons -or inflammatory cells- have emerged as neuro-immune modulators that can relay, for instance, stress-induced neuronal activity to immune processes. Such peptides can participate in processes reducing inflammatory responses, or augment resolution of inflammation. Neuropeptides and hormones such as vasoactive intestinal peptide, urocortin, ghrelin, and cortistatin have been shown to modulate the disease activity in a variety of experimental models of inflammatory and autoimmune disease via modulation of immune or neuronal cell activity. We review here the potential of neuropeptide receptor activation to modulate inflammatory diseases. We will highlight the role of neuropeptides in gastrointestinal (GI) physiology and immune regulation, and we will speculate on the therapeutic potential of peptides that bind G protein coupled receptors (GPCRs) in the management of inflammation in the GI tract.

Keywords: Neuropeptide receptors, G protein coupled receptors (GPCRs), protease-activated receptors (PARs), neuro-immune connection, enteric nervous system (ENS), irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD), postoperative ileus (POI), intestine

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [1091 - 1105]
Pages: 15
DOI: 10.2174/138161210790963814
Price: $65

Article Metrics

PDF: 16